Companies Dominating the Human Combinatorial Antibody Libraries (HuCAL) Market
- MorphoSys A.G.
- Company Overview
- Business Planning
- Main Product Offerings
- Financial Execution
- Main Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Bio-Rad
- Adimab, LLC
- Taurus Biosciences
- ImmunoGen
- BioInvent International AB
- Creative Biolabs
- YUMAB GmbH
- Hoffman-La Roche Ltd.
- Creative Biolabs
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of human combinatorial antibody libraries is estimated at USD 169.85 million.
The human combinatorial antibody libraries market size was over USD 163.06 million in 2024 and is anticipated to cross USD 303.69 million by 2037, witnessing more than 4.9% CAGR during the forecast period i.e., between 2025-2037. Continuously increasing burden of hepatitis across the world will fuel the market growth.
North America industry is poised to hold largest revenue share of 35% by 2037, owing to increasing advancement in creating antibodies for reproducible research.
The major players in the market are Bio-Rad, MorphoSys A.G., Taurus Biosciences, ImmunoGen, BioInvent International AB, Creative Biolabs, YUMAB GmbH, Hoffman-La Roche Ltd., Creative Biolabs, Astellas Pharma Inc., Shinogi Inc., Koutai Shokunin, Daichi Sankyo Co., Ltd.
